Findings from a study published in NEJM suggest that a key treatment for opioid use disorder is underprescribed among patients in the United States, in particular among Black patients.

To prevent misuse, abuse, and addiction of prescription stimulants, FDA is now requiring their boxed warning—the most prominent warning—to be updated. In addition, the agency is adding more to the prescribing information for all prescription stimulants.

CDC reported that two cases of drug-resistant ringworm infections involving the fungus Trichophyton indotineae were identified in New York City, the first such cases in the country.

DEA has said that for now it is extending emergency telehealth policies set during the COVID-19 pandemic, enabling certain health care providers to have greater leeway in prescribing some controlled substances.

FDA approved GSK’s respiratory syncytial virus (RSV) vaccine (Arexvy) for adults aged 60 years and older.